CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 144 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,000 | -85.7% | 1,823 | -87.4% | 0.00% | -100.0% |
| Q2 2017 | $35,000 | – | 14,420 | +360400.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 4 | -100.0% | 0.00% | -100.0% |
| Q1 2016 | $50,000 | -24.2% | 13,281 | +212.6% | 0.00% | -20.0% |
| Q4 2015 | $66,000 | +34.7% | 4,248 | -9.3% | 0.01% | +25.0% |
| Q3 2015 | $49,000 | -54.6% | 4,681 | +9.0% | 0.00% | -55.6% |
| Q2 2015 | $108,000 | -81.8% | 4,296 | -79.8% | 0.01% | -87.0% |
| Q1 2015 | $593,000 | +187.9% | 21,289 | +88.9% | 0.07% | +176.0% |
| Q4 2014 | $206,000 | – | 11,270 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
| Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
| TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
| GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
| Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
| Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
| Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
| LMR Partners LLP | 408,846 | $206,000 | 0.01% |